Tarek Baati | Nanobiotechnology | Best Scholar Award

Posted on by ScienceFather

Dr. Tarek Baati | Nanobiotechnology | Best Scholar Award

Dr. Tarek Baati, Institut National de Recherche et d’Ananlyse Physicochimique, Tunisia

Dr. Tarek Baati is a seasoned toxicologist and Senior Lecturer based in Tunisia. With an HDR from the Institut SupΓ©rieur de biotechnologie de Monastir in 2022, his extensive educational background includes a PhD in Toxicology from the University Paris11 in 2009. Dr. Baati has diverse expertise, from analytical chromatography to animal surgery techniques acquired during his formations in France. Proficient in languages such as French, English, and Arabic, he excels in in vitro, ex-vivo, and in vivo testing, tumor model development, and nanoparticle safety studies. Dr. Baati actively contributes to research, supervising students, and serving as a reviewer for Q1 Journals. His passion extends beyond science, embracing football, chess, photography, and DIY projects. πŸ§ͺπŸ“šπŸ”¬

πŸŽ“ Education & Qualifications:

2022: HDR (Institut SupΓ©rieur de Biotechnologie de Monastir). 2013: Analytical Chromatography and Separation Techniques, IUT- Orsay (France). 2012: Animal Surgery Techniques (Marseille, France). 2011: Transmission Electron Microscopy Techniques (Orsay, France). 2009: PhD in Toxicology, Faculty of Pharmacy, University Paris11. 2005: Master in Biology and Health, Institut SupΓ©rieur de Biotechnologie de Monastir.

πŸ–₯️ Informatics:

Proficient in Pack Office 2010, social networks, HPLC software (Empower, Chromquest), Image processing: ImageJ, Corel 12, Statistics (SPSS11)

πŸ”¬ Technical Skills:

Conducts in vitro, ex-vivo, and in vivo tests. Cell line culture and IC50 analysis. Migration tests in transwell chambers and immuno-fluorescence. Development of tumor models in nude mice. Study of nanoparticles safety and biodistribution. Application of nanoparticles for drug delivery and detoxification. Analysis of histopathological examination of organs. Extraction, purification, and testing of natural substances. Development and validation of analytical methods by HPLC-PDA. Assessment of biochemical markers. Supervision of Ph.D. and Master degree students. Reviewer for several Q1 Journals. Organization and participation in scientific meetings. Teaching toxicology and biochemistry.

πŸ… Various:

Member of the Tunisian Association of Toxicology, Faculty of Pharmacy of Monastir. Interests: Football, Chess, Photography, DIY.

Professional Profiles:

The impact of her research is evident in citation metrics and indices from Google Scholar:

  • Cited by: All – 10271.
  • Citations – 10271.
  • h-index – 20.
  • Documents – 40.

A prolific researcher making meaningful contributions to the academic world!

πŸ”¬ Research Focus:

Dr. Tarek Baati’s research primarily focuses on the development and application of porous metal–organic-framework (MOF) nanoscale carriers for drug delivery and imaging, as evidenced by his extensive citations in the field. His work spans various aspects, including the use of MOFs in biomedicine, in-depth analysis of the in vivo toxicity of porous iron (III) MOFs, and the design of biodegradable therapeutic MOFs for delivering bioactive molecules. Additionally, he explores innovative approaches such as enhancing anti-HIV activity through MOF nanoparticles. Dr. Baati’s contributions also extend to studying the effects of nanomaterials on lifespan and investigating preventive measures against chromosome aberrations induced by certain compounds. πŸ§ͺπŸ”¬πŸŒ

Publications Top Note:

Sharon Vijayanand | Nanobiotechnology | Best Researcher Award

Posted on by ScienceFather

Dr. Sharon Vijayanand | Nanobiotechnology | Best Researcher Award

Dr. Sharon Vijayanand, FDA/CBER/OTP/OPPT, United States

πŸŒπŸ’‰πŸ”¬ Dr. Sharon Vijayanand, a dedicated researcher and pharmaceutical scientist, earned her Ph.D. in Pharmaceutical Sciences from Mercer University, focusing on a groundbreaking pain-free immunization strategy for COVID-19 and influenza. As an ORISE Fellow at the FDA, she explores FcRn-mediated dynamics of anti-SARS CoV-2 IgG. With a rich academic background and extensive experience, including roles as a Graduate Research Assistant and Pharmacy Technician, she has received numerous awards for her impactful contributions. Dr. Vijayanand is a dynamic leader, fostering collaborations in professional organizations like AAPS and Toastmasters, showcasing her commitment to scientific advancement and effective communication. πŸ₯πŸ‘©β€πŸ”¬πŸ†

πŸŽ“ Education:

Ph.D. in Pharmaceutical Sciences (Jan 2020 – July 2023) from Mercer University College of Pharmacy, Atlanta, GA, USA. Dissertation Title: “Novel Pain-Free Immunization of a Combination Microparticulate Vaccine for COVID-19 and Influenza.” B. Pharm. (Sept 2015 – Sept 2019) from Dr. M.G.R. Medical University, Chennai, TN, India. Thesis Title: “In Silico Molecular Docking Study of Anti-Breast Cancer Molecules Derived from Plants.”

πŸ‘©β€πŸ”¬ Professional Experience:

ORISE Fellow (Jan 2024 – Present) at FDA/CBER/OPT/OPPT, Silver Spring, MD, USA. Researching FcRn-Mediated Dynamics of Anti-SARS CoV-2 IgG. Graduate Research Assistant and Teaching Assistant (Jan 2020 – July 2023) at Mercer University College of Pharmacy, Atlanta, GA, USA. Conducted preclinical testing of micro/nanoparticle-based non-invasive vaccines, resulting in publications and awards. Optimized brain-targeted nanoparticle formulation for seizure therapy (NIH R01 Project). Developed experimental protocols for SARS-CoV-2 and Influenza assays. Mentored junior graduate and Pharm D students. Pharmacy Technician (Dec 2019 – Jan 2022) at CVS Health, Atlanta, GA, USA. Front-line healthcare worker during the COVID-19 pandemic. Undergraduate Thesis Project Team Lead (Sept 2018 – Aug 2019) at Dr. M.G.R. Medical University, Chennai, TN, India. Led a team of 4 for a molecular docking study.

🌐 Professional Affiliations and Leadership Roles:

American Association of Pharmaceutical Sciences (AAPS): Learning Opportunities Manager, AAPS Pharmaceutical Discovery and Preclinical Development Community. Member Engagement Manager, AAPS Women in Pharmaceutical Science Community. Treasurer, Mercer University AAPS Student Chapter. Public Relations Officer, Mercer University AAPS Student Chapter. Toastmaster International (Mercer Smooth Talkers): Secretary and President. Other Affiliations: Student Member, The American Society for Microbiology (ASM). Member, The Honor Society of Phi Kappa Phi.

πŸ† Awards and Honors:

Love of Learning Scholarship Award, Phi Kappa Phi. Monroe F. Swilley Jr. Student Research Award, Mercer University. Various awards at AAPS meetings, including Best Abstract and Best Poster Awards. Keynote Speaker at the 2022 AAPS PharmSci 360 meeting.

Professional Profiles:

The impact of her research is evident in citation metrics and indices from Google Scholar:

  • Cited by: All – 60.
  • Citations – 60.
  • h-index – 4.
  • Documents – 15.

A prolific researcher making meaningful contributions to the academic world!

πŸ”¬ Research Focus:

πŸ©ΉπŸ’‰πŸ”¬ Dr. Sharon Vijayanand, based at FDA/CBER/OTP/OPPT in the United States, specializes in developing innovative vaccine delivery platforms. Her impactful research centers on a dual-delivery system using antigen-loaded nanoparticles in dissolving microneedles, garnering 21 citations in 2022. Notably, her work extends to Zika and SARS-CoV-2 vaccines, employing microparticulate and microneedle technologies to induce robust immune responses. With a focus on influenza and gonococcal vaccines, she explores T-cell potential and enhances bacterial clearance. Dr. Vijayanand’s contributions mark a significant advancement in vaccination strategies, employing cutting-edge techniques for targeted and efficient immune response elicitation. πŸ’ŠπŸ‘©β€πŸ”¬πŸŒ

Publications Top Note: